Human Umbilical Cord Mesenchymal Stem Cell Treatment Alleviates Symptoms in an Atopic Dermatitis-Like Mouse Model
May 2023
in “
Stem Cell Research & Therapy
”
human umbilical cord mesenchymal stem cells mesenchymal stem cells MSC atopic dermatitis immune response inflammatory response filaggrin lipid metabolism inflammatory cytokines IL-1β JAK-STAT pathway IgE receptor hair follicle development hair growth stem cell therapy MSC therapy immune modulation inflammation reduction skin barrier function cytokine reduction hair growth promotion
TLDR Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.
The study demonstrates that human umbilical cord mesenchymal stem cell (MSC) treatment significantly alleviates symptoms in a mouse model of atopic dermatitis (AD) by modulating immune and inflammatory responses. In a study involving 24 mice, MSC treatment reduced scratching frequencies, dermatitis scores, and ear thickness, and improved skin barrier function by restoring gene expression related to filaggrin and lipid metabolism. It also decreased inflammatory cytokines like IL-1β and modulated the JAK-STAT pathway and IgE receptor expression. Additionally, MSC treatment unexpectedly promoted hair follicle development, suggesting potential benefits for hair growth. These findings highlight MSC therapy's potential for personalized treatment strategies in managing AD, though further clinical studies are needed to assess long-term safety and efficacy.
